Skip to main content

Table 3 Association between mean change LV GLS and baseline variables

From: Effect of etelcalcetide versus alfacalcidol on left ventricular function and feature-tracking cardiac magnetic resonance imaging in hemodialysis—a post-hoc analysis of a randomized, controlled trial

  

95%CI

p-value

 

Coefficient

LCI

UCI

 

Univariate analysis

 Age

− 0.02

− 0.14

0.10

0.750

 Male sex

3.29

0.53

6.06

0.020

 Diabetes

1.53

− 0.98

4.03

0.226

 Hypertension

2.00

− 6.87

10.86

0.652

 Months on dialysis

0.003

− 0.122

0.128

0.960

 Etelcalcetide (ETL) treatment

− 2.69

− 5.12

− 0.26

0.039

Multivariate analysis

 Etelcalcetide (ETL) treatment

− 2.62

− 5.10

− 0.14

0.042

  1. Regression models demonstrating the association between mean change of LV GLS from baseline variables. The multivariate model includes baseline LV GLS sex, LV mass change, and FGF23 change; per-protocol dataset
  2. FGF23: Fibroblast growth factor 23, GLS: global longitudinal strain, LV: left ventricle